Connection
Ping-Ching Hsu to Disease Management
This is a "connection" page, showing publications Ping-Ching Hsu has written about Disease Management.
|
|
Connection Strength |
|
 |
|
 |
|
0.043 |
|
|
|
-
Wu CE, Chang CF, Huang CY, Yang CT, Kuo CS, Hsu PC, Chang JW. Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study. BMC Cancer. 2021 Jul 27; 21(1):859.
Score: 0.043